Status:
COMPLETED
Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control (HbA1c) using NovoRapid® (insulin aspart) and Levemir® (insulin detemir) after switch fr...
Eligibility Criteria
Inclusion
- Any subject with type 1 diabetes who is treated with human rapid and intermediate (NPH) insulin in basal-bolus regimen
Exclusion
- Subjects currently being treated with insulin aspart and insulin detemir
- Subjects who were previously enrolled in this study
- Subjects with a hypersensitivity to insulin aspart or to any of the excipients
- Subjects with a hypersensitivity to insulin detemir or to any of the excipients
- Women who are pregnant or have the intention of becoming pregnant within next 6 months
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
417 Patients enrolled
Trial Details
Trial ID
NCT00873639
Start Date
April 1 2009
End Date
November 1 2009
Last Update
October 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Bucharest, Romania, 010031